RevenueNet IncomeP/EP/SEBITDividendStocksMarket capitalizationDebtLiabilitiesEquityAAQSEmployeesROEROAROCE
Mersana Therapeutics Stock

Mersana Therapeutics P/E 2024

Mersana Therapeutics P/E

-3.07

Ticker

MRSN

ISIN

US59045L1061

WKN

A2DTR7

As of Sep 22, 2024, Mersana Therapeutics's P/E ratio was -3.07, a -40.04% change from the -5.12 P/E ratio recorded in the previous year.

The Mersana Therapeutics P/E history

Mersana Therapeutics Aktienanalyse

What does Mersana Therapeutics do?

Mersana Therapeutics Inc is a biotechnology company based in Cambridge, Massachusetts, USA. Founded in 2001, the company focuses on developing novel targeted cancer therapies based on the innovative Targeted Payload Apex platform. The company's pipeline includes multiple product candidates in various stages of clinical development, including XMT-1536 and XMT-1592. Mersana Therapeutics Inc collaborates with leading oncologists, scientists, and research institutes to advance its technologies and develop high-quality, safe, and effective therapies for cancer patients. The company's business model is based on utilizing its technology platform and product discovery capabilities to develop novel drugs. It is divided into different business areas targeting different medical applications, including oncology, ophthalmology, immunology, and metabolic diseases. Mersana Therapeutics Inc aims to improve the efficacy, safety, and tolerance of cancer therapies and meet the unmet medical need for targeted cancer treatments. Mersana Therapeutics ist eines der beliebtesten Unternehmen auf Eulerpool.com.

P/E Details

Deciphering Mersana Therapeutics's P/E Ratio

The Price to Earnings (P/E) Ratio of Mersana Therapeutics is a vital metric that investors and analysts use to determine the company’s market value relative to its earnings. It is calculated by dividing the current stock price by the earnings per share (EPS). A higher P/E ratio could suggest that investors are expecting higher future growth, while a lower ratio may indicate a potentially undervalued company or lower growth expectations.

Year-to-Year Comparison

Assessing Mersana Therapeutics's P/E ratio on a yearly basis provides insights into the valuation trends and investor sentiment. An increasing P/E ratio over the years signifies growing investor confidence and expectations for future earnings growth, while a decreasing ratio may reflect concerns over the company's profitability or growth prospects.

Impact on Investments

The P/E ratio of Mersana Therapeutics is a key consideration for investors aiming to balance risk and reward. A comprehensive analysis of this ratio, in conjunction with other financial indicators, aids investors in making informed decisions regarding buying, holding, or selling the company’s stocks.

Interpreting P/E Ratio Fluctuations

Fluctuations in Mersana Therapeutics’s P/E ratio can be attributed to various factors including changes in earnings, stock price movements, and shifts in investor expectations. Understanding the underlying reasons for these fluctuations is essential for predicting future stock performance and assessing the company's intrinsic value.

Frequently Asked Questions about Mersana Therapeutics stock

What is the price-to-earnings ratio of Mersana Therapeutics?

The price-earnings ratio of Mersana Therapeutics is currently -3.07.

How has the price-earnings ratio of Mersana Therapeutics changed compared to last year?

The price-to-earnings ratio of Mersana Therapeutics has increased by -40.04% fallen (meaning "decreased" or "dropped") compared to last year.

What consequences does a high price-earnings ratio have for investors?

A high price-to-earnings ratio indicates that the company's stock is relatively expensive and investors may potentially achieve a lower return.

What does a low price-earnings ratio mean?

A low price-earnings ratio means that the company's stock is relatively cheap and investors may potentially achieve a higher return.

Is the price-earnings ratio of Mersana Therapeutics high compared to other companies?

Yes, the price-to-earnings ratio of Mersana Therapeutics is high compared to other companies.

How does an increase in the price-earnings ratio of Mersana Therapeutics affect the company?

An increase in the price-earnings ratio of Mersana Therapeutics would lead to a higher market capitalization of the company, which in turn would lead to a higher valuation of the company.

How does a reduction in the price-to-earnings ratio of Mersana Therapeutics affect the company?

A decrease in the price-earnings ratio of Mersana Therapeutics would result in a lower market capitalization of the company, which in turn would lead to a lower valuation of the company.

What are some factors that influence the price-earnings ratio of Mersana Therapeutics?

Some factors that influence the price-earnings ratio of Mersana Therapeutics are the company's growth, financial position, industry development, and the overall economic situation.

How much dividend does Mersana Therapeutics pay?

Over the past 12 months, Mersana Therapeutics paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Mersana Therapeutics is expected to pay a dividend of 0 USD.

What is the dividend yield of Mersana Therapeutics?

The current dividend yield of Mersana Therapeutics is .

When does Mersana Therapeutics pay dividends?

Mersana Therapeutics pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of Mersana Therapeutics?

Mersana Therapeutics paid dividends every year for the past 0 years.

What is the dividend of Mersana Therapeutics?

For the upcoming 12 months, dividends amounting to 0 USD are expected. This corresponds to a dividend yield of 0 %.

In which sector is Mersana Therapeutics located?

Mersana Therapeutics is assigned to the 'Health' sector.

Wann musste ich die Aktien von Mersana Therapeutics kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Mersana Therapeutics from 9/22/2024 amounting to 0 USD, you needed to have the stock in your portfolio before the ex-date on 9/22/2024.

When did Mersana Therapeutics pay the last dividend?

The last dividend was paid out on 9/22/2024.

What was the dividend of Mersana Therapeutics in the year 2023?

In the year 2023, Mersana Therapeutics distributed 0 USD as dividends.

In which currency does Mersana Therapeutics pay out the dividend?

The dividends of Mersana Therapeutics are distributed in USD.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

The Mersana Therapeutics stock can be added to a savings plan with the following providers: Trade Republic

Andere Kennzahlen von Mersana Therapeutics

Our stock analysis for Mersana Therapeutics Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Mersana Therapeutics Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.